Upgrade to SI Premium - Free Trial

EMA validates Pfizer and Valneva's Lyme disease vaccine application

August 14, 2026 1:00 AM
Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) announced that the European Medicines Agency (EMA) has ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA